Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex

Acta Neurologica Scandinavica

Volumn 111, Issue 1, 2005, Pages 54-63

  Ali, M ^a   Girimaji, S C ^b   Markandaya, M ^a   Shukla, A K ^c   Sacchidanand, S ^d   Kumar, Arun ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Bangalore Medical College   (India)

Author keywords

DNA sequencing; Indian patients; Mutations; PCR SSCP; Polymorphisms; Promoters; TSC1; TSC2

Indexed keywords

TUBERIN;

ARTICLE; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; INDIA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; TSC1 GENE; TSC2 GENE; TUBEROUS SCLEROSIS;

AMINO ACID SEQUENCE; CODON, NONSENSE; GENE DELETION; GENETIC SCREENING; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA SPLICE SITES; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 12744272180     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2004.00366.x     Document Type: Article

References (31)

1. ROACH ES, GOMEZ MR, NORTHRUP H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-8.
2. CURATOLO P. Neurological manifestations of tuberous sclerosis complex. Childs Nerv Syst 1996;12:515-21.
3. O'CALLAGHAN FJ, SHIELL AW, OSBORNE JP, MARTYN CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 1998;351:1490.
4. FRYER AE, CHALMERS A, CONNOR JM et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987;1:659-61.
5. KANDT RS, HAINES JL, SMITH M et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37-41.
6. VAN SLEGTENHORST M, DE HOOGT R, HERMANS C et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-8.
7. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome16. Cell 1993;75:1305-15.
8. KRYMSKAYA VP. Tumour suppressors hamartin and tuberin: intracellular signalling. Cell Signal 2003;15:729-39.
9. VAN SLEGTKNHORST M, NELLIST M, NAGELKERKEN B et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998;7:1053-7.
10. LAMB RF, ROY C, DIEFENBACH TJ et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2000;2:281-7.
11. HGMD. Human gene mutation database Available online at http://www.uwcm.ac.uk/uwcm/mg/hgmd0.html. Last accessed November 2nd, 2004.
12. EL-HASHEMITE N, ZHANG H, HENSKE EP, KWIATKOWSKI DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 2003;361:1348-9.
13. YAMAMOTO T, PIPO JR, FENG JH et al. Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex. Brain Dev 2002;24:227-30.
14. CHEADLE JP, REEVE MP, SAMPSON JR, KWIATKOWSKI DJ. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000;107:97-114.
15. World Health organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guideline. Delhi: Oxford University Press, 1992.
16. MALIN AJ. Vineland. Social Maturity Scale (Nagpur adaptation). Lucknow: Indian Psychological Corporation, 1970.
17. DOLL EA. Vineland Social Maturity Scale: Manual for direction (revised edition). Minneapolis: education Trust Bureau (Current American Guidance Service), 1965.
18. ALI M, GIRIMAJI SC, KUMAR A. Identification of a core promoter and a novel isoform of the human TSC1 gene transcript and structural comparison with mouse homolog. Gene 2003;320:145-54.
19. IKEDA S, MOCHIZUKI A, SARKKR AH, SEKI S. Identification of functional elements in the bidirectional promoter of the mouse Nth11 and Tsc2 genes. Biochem Biophys Res Commun 2000;273:1063-8.
20. KUMAR A, KANDT RS, WOLPERT C, ROSES AD, PERICAK-VANCE MA, GILBERT JR. Mutation analysis of the TSC2 gene in an African-American family. Hum Mol Genet 1995;4:2295-8.
21. KRAWCZAK M, REISS J, COOPER DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90:41-54.
22. NOONAN DJ, LOU D, GRIFFITH N, VANAMAN TC. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis. Arch Biochem Biophys 2002;398:132-40.
23. VRTEL R, VERHOEF S, BOUMAN K et al. Identification of a nonsense mutation at the 5′ end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex. J Med Genet 1996;33:47-51.
24. REIERSEN H, REES AR. The hunchback and its neighbours: proline as an environmental modulator. Trends Biochem Sci 2001;26:679-84.
25. HEINKOFF S, HEINKOFF JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992;89:10915-9.
26. LEVIN JM, GARNIER J. Improvements in a secondary structure prediction method based on a search for local sequence homologies and its use as a model building tool. Biochem Biophys Acta 1988;955:283-95.
27. NELLIST M, VERHAAF B, GOEDBLOED MA, REUSER AJ, VAN DEN OUWELAND AM, HALLEY DJ. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Hum Mol Genet 2001;10:2889-98.
28. JEGANATHAN D, FOX MF, YOUNG JM, YATES JR, OSBORNE JP, POVEY S. Nonsense-medialed RNA decay in the TSC1 gene suggests a useful tool pre- and post-positional cloning. Hum Genet 2002;111:555-65.
29. ZHANG H, NANBA E, YAMAMOTO T et al. Mutational analysis of TSC1 and TSC2 genes in Japanese patients with tuberous sclerosis complex. J Hum Genet 1999;44:391-6.
30. DABORA SL, JOZWIAK S, FRANZ DN et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
31. GILBERT JR, GUY V, KUMAR A et al. Mutation and polymorphism analysis in the tuberous sclerosis 2 (TSC2) gene. Neurogenetics 1998;1:267-72.